Jordi Rello

ORCID: 0000-0003-0676-6210
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nosocomial Infections in ICU
  • Pneumonia and Respiratory Infections
  • Respiratory Support and Mechanisms
  • Sepsis Diagnosis and Treatment
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Respiratory viral infections research
  • Antibiotics Pharmacokinetics and Efficacy
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Influenza Virus Research Studies
  • Emergency and Acute Care Studies
  • Antifungal resistance and susceptibility
  • Intensive Care Unit Cognitive Disorders
  • Bacterial Identification and Susceptibility Testing
  • Central Venous Catheters and Hemodialysis
  • Antimicrobial Resistance in Staphylococcus
  • COVID-19 Clinical Research Studies
  • Inhalation and Respiratory Drug Delivery
  • Mechanical Circulatory Support Devices
  • Transplantation: Methods and Outcomes
  • Hemodynamic Monitoring and Therapy
  • Airway Management and Intubation Techniques
  • Cardiac Arrest and Resuscitation
  • Long-Term Effects of COVID-19
  • Fungal Infections and Studies

Université de Nîmes
2020-2025

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
2016-2025

Vall d'Hebron Institut de Recerca
2016-2025

Université de Montpellier
2020-2025

Centro de Investigación Biomédica en Red
2015-2025

Instituto de Salud Carlos III
2016-2025

Centre Hospitalier Universitaire de Nîmes
2020-2025

Vall d'Hebron Hospital Universitari
2014-2024

Universitat Internacional de Catalunya
2020-2024

Network Group (Czechia)
2023

Jason A. Roberts Sanjoy K. Paul Murat Akova Matteo Bassetti Jan J. De Waele and 95 more George Dimοpoulos Kirsi-Maija Kaukonen Despoina Koulenti Claudio M. Martin P. Montravers Jordi Rello Andrew Rhodes T. Starr S. C. Wallis Jeffrey Lipman Jason A. Roberts Jeffrey Lipman T. Starr Steven C. Wallis Sanjoy K. Paul A. S. Margarit Jan J. De Waele Luc De Crop Herbert Spapen Joost Wauters Thierry Dugernier Philippe G. Jorens I. Dapper Daniel De Backer Fabio Silvio Taccone Jordi Rello Laura Ruano Elsa Afonso Francisco Álvarez-Lerma M.P. Gracia-Arnillas Francisco Arnalich Nícolas de Albuquerque Pereira Feijóo N. Bardolet A Rovira Pau Garro Diego Colón C. Castillo J. Fernado María José López José Luís Fernández Alfredo Arribas J. L. Teja Elsa Ots Juan Carlos Montejo M. S. Catalán I. Prieto G. Gonzalo Beatriz Galván M. A. Blasco EC Meyer F. Del Nogal Loreto Vidaur Rafael Sebastián P. M. Garde M. d. M. Martin Velasco Rafael Zaragoza M. Esperatti A. Torres P. Montravers Olivier Baldési H. Dupont Yazine Mahjoub Sigismond Lasocki Jean-Michel Constantin Jean‐François Payen Claudio M. Martin J. Albanèse Yannick Mallédant Julien Pottecher Jean Yves Lefrant S. Jaber O. Joannes-Boyau Carmen Orban Marlies Ostermann Catherine McKenzie W. R. Berry Julie Smith K Lei Francesca Rubulotta Anthony Gordon Stephen J. Brett M. Stotz M. Templeton Andrew Rhodes Claudia Ebm Cristiane Aparecida Moran Kirsi-Maija Kaukonen Ville Pettilä George Dimοpoulos Despoina Koulenti A. Xristodoulou Vasiliki Theodorou Georgios Kouliatsis Eleni Sertaridou George Anthopoulos

Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam antibiotic dosing in achieves concentrations associated maximal activity affect patient outcome.This was prospective, multinational pharmacokinetic point-prevalence study including 8 antibiotics. Two blood samples were taken from each during single interval. The primary pharmacokinetic/pharmacodynamic targets free above the minimum inhibitory...

10.1093/cid/ciu027 article EN Clinical Infectious Diseases 2014-01-14

In order to assess potential risk factors for pneumonia within the first 8 d of ventilation, we studied 83 consecutive intubated patients undergoing continuous aspiration subglottic secretions (CASS). Multivariate analysis showed protective effect antibiotic use (relative [RR] = 0.10; 95% confidence interval [CI] 0.01 0.71), whereas failure CASS technique (RR 5.29; CI 1.24 22.64) was associated with a greater pneumonia. addition, there trend toward higher 2.57; 0.78 8.03) among persistent...

10.1164/ajrccm.154.1.8680665 article EN American Journal of Respiratory and Critical Care Medicine 1996-07-01

Rationale: The clinical relevance of Aspergillus-positive endotracheal aspirates in critically ill patients is difficult to assess.Objectives: We externally validate a algorithm discriminate Aspergillus colonization from putative invasive pulmonary aspergillosis this patient group.Methods: performed multicenter (n = 30) observational study including with one or more aspirate cultures 524). diagnostic accuracy was evaluated using 115 histopathologic data, considered the gold standard....

10.1164/rccm.201111-1978oc article EN American Journal of Respiratory and Critical Care Medicine 2012-04-20

The use of microbiologic investigations in routine clinical practice, their value guiding antibiotic prescription, and influence on outcome were prospectively studied 113 consecutive adults who developed ventilator-associated pneumonia (VAP). Blood cultures performed 78.7% cases, protected specimen brushing 95.5%, bronchoalveolar lavage only 45.1%. No causative agent was identified 13 episodes (11.5%), results microbial tests directed a change therapy 43 (38.0%). Bronchoscopic revealed...

10.1164/ajrccm.156.1.9607030 article EN American Journal of Respiratory and Critical Care Medicine 1997-07-01

Abstract Introduction Patients with influenza A (H1N1)v infection have developed rapidly progressive lower respiratory tract disease resulting in failure. We describe the clinical and epidemiologic characteristics of first 32 persons reported to be admitted intensive care unit (ICU) due Spain. Methods used medical chart reviews collect data on ICU adult patients a standardized form. Influenza was confirmed specimens using real-time reverse transcriptase-polymerase-chain-reaction (RT PCR)...

10.1186/cc8044 article EN cc-by Critical Care 2009-09-11

We performed a prospective, international, observational study of 844 hospitalized patients with blood cultures positive for Streptococcus pneumoniae. Fifteen percent isolates had in vitro intermediate susceptibility to penicillin (minimum inhibitory concentration [MIC], 0.12–1 μg/mL), and 9.6% were resistant (MIC, ⩾2 μg/mL). Age, severity illness, underlying disease immunosuppression significantly associated mortality; resistance was not risk factor mortality. The impact concordant...

10.1086/377534 article EN Clinical Infectious Diseases 2003-07-15

Retrospective studies have suggested that combination antibiotic therapy for severe bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a prospective, multicenter, international observational study of 844 adult patients with bacteremia due to Streptococcus pneumoniae. The effect versus monotherapy on mortality was examined by univariate analyses and logistic regression models. 14-day not significantly different the two groups. However, among critically ill...

10.1164/rccm.200311-1578oc article EN American Journal of Respiratory and Critical Care Medicine 2004-06-08

All episodes of ventilator-associated pneumonia (VAP) caused by Staphylococcus aureus were prospectively analyzed for a 30-mo period. Methicillin-sensitive S. (MSSA) was isolated in 38 and methicillin-resistant (MRSA) 11 others. The two groups similar regarding sex, severity underlying diseases, prior surgery, presence renal failure, diabetes, cardiopathy, coma. MRSA-infected persons more likely to have received steroids before developing infection (relative risk [RR] = 3.45, 95% confidence...

10.1164/ajrccm.150.6.7952612 article EN American Journal of Respiratory and Critical Care Medicine 1994-12-01

Objective Pseudomonas aeruginosa is a frequent cause of ventilator-associated pneumonia. Recent evidence suggests that production type III secretion proteins correlated with increased pathogenicity in both cellular and animal models infection. The objective this study was to determine whether system contributes disease severity humans Design Retrospective pilot cohort study. Setting University hospital. Patients Thirty-five mechanically ventilated patients bronchoscopically confirmed...

10.1097/00003246-200203000-00005 article EN Critical Care Medicine 2002-03-01

Abstract Introduction Invasive aspergillosis (IA) is a fungal infection that particularly affects immunocompromised hosts. Recently, several studies have indicated high incidence of IA in intensive care unit (ICU) patients. However, few data are available on the epidemiology and outcome patients with this setting. Methods An observational study including all positive Aspergillus culture during ICU stay was performed 30 ICUs 8 countries. Cases were classified as proven IA, putative or...

10.1186/s13054-014-0722-7 article EN cc-by Critical Care 2015-01-09

Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences early both mild severe patients infected nvH1N1.We profiled 29 cytokines chemokines evaluated haemagglutination inhibition activity as quantitative qualitative measurements responses serum obtained during first five days after symptoms onset, two cohorts nvH1N1 patients. Severe...

10.1186/cc8208 article EN cc-by Critical Care 2009-12-11

Abstract Background Antibiotics may be indicated in patients with COVID-19 due to suspected or confirmed bacterial superinfection. Objectives To investigate antibiotic prescribing practices COVID-19. Methods We performed an international web-based survey and investigated the pattern of use as reported by physicians involved treatment SPSS Statistics version 25 was used for data analysis. Results The completed 166 participants from 23 countries 82 different hospitals. Local guidelines were...

10.1093/jac/dkaa326 article EN other-oa Journal of Antimicrobial Chemotherapy 2020-07-09

Pseudomonas aeruginosa nosocomial pneumonia (Pa-NP) is associated with considerable morbidity, prolonged hospitalization, increased costs, and mortality.We conducted a retrospective cohort study of adult patients Pa-NP to determine 1) risk factors for multidrug-resistant (MDR) strains 2) whether MDR increases the hospital death. Twelve hospitals in 5 countries (United States, n = 3; France, 2; Germany, Italy, Spain, 3) participated. We compared characteristics who had those did not derived...

10.1186/s13054-015-0926-5 article EN cc-by Critical Care 2015-04-30
Coming Soon ...